×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [70]
内容类型
期刊论文 [51]
会议论文 [19]
发表日期
2019 [3]
2018 [6]
2017 [10]
2016 [14]
2015 [5]
2014 [7]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共70条,第1-10条
帮助
限定条件
专题:复旦大学上海医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Identification of luminal A-like subgroup among ER+/PR+/HER2+breast cancers and its clinical implications
会议论文
作者:
Zhao, S.
;
Jin, X.
;
Jiang, Y-Z
;
Shao, Z-M
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Subgroup Analysis for Chinese Patients Included in the INPULSIS (R) Trials on Nintedanib in Idiopathic Pulmonary Fibrosis
期刊论文
ADVANCES IN THERAPY, 2019, 卷号: 36, 期号: 3
作者:
Xu, Zuojun
;
Li, Huiping
;
Wen, Fuqiang
;
Bai, Chunxue
;
Chen, Ping
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2019/12/05
Asians
Chinese
Efficacy
Forced vital capacity
Idiopathic pulmonary fibrosis
INPULSIS (R)
Nintedanib
Randomized controlled trial
Respiratory
Safety
Add-on Tiotropium in Chinese Patients With Moderate Asthma: A Pooled Subgroup Analysis of MezzoTinA-Asthma 1 and 2
期刊论文
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 卷号: 11, 期号: 4
作者:
Lin, Jiangtao
;
Wan, Huanying
;
Kang, Jian
;
Ma, Qianli
;
Chen, Ping
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2019/12/05
Adult
asthma
Chinese
tiotropium
efficacy
Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study
期刊论文
BMC CANCER, 2018, 卷号: 18
作者:
Ye, Sheng-Long
;
Yang, Jiamei
;
Bie, Ping
;
Zhang, Shuijun
;
Chen, Xiaoping
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/05
Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
期刊论文
THERANOSTICS, 2018, 卷号: 8, 期号: 22
作者:
Liu, Xi-Yu
;
Ma, Ding
;
Xu, Xiao-En
;
Jin, Xi
;
Yu, Ke-Da
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
ER+PR-HER2-
endocrine resistance
multiomic
non-luminal-like
breast cancer
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study
期刊论文
JOURNAL OF NEURO-ONCOLOGY, 2018, 卷号: 140, 期号: 3
作者:
Ding, Xiaojie
;
Wang, Zheng
;
Chen, Di
;
Wang, Yinyan
;
Zhao, Zheng
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
Glioma
Extent of resection
Prognostic value
Molecular subgroup
Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON)
期刊论文
BREAST CANCER, 2018, 卷号: 25, 期号: 3
作者:
Noguchi, Shinzaburo
;
Ellis, Matthew J.
;
Robertson, John F. R.
;
Thirlwell, Jackie
;
Fazal, Mehdi
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/05
Asian
Anastrozole
Fulvestrant
Progression-free survival
Safety
Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma
期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:
Wang, Xilong
;
Zhang, Jun
;
Wang, Yangyun
;
Tu, Minqi
;
Wang, Ying
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
clear cell renal cell carcinoma
differentially expressed genes
protein-protein interaction network
subgroup analysis
survival analysis
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study
期刊论文
CHINESE MEDICAL JOURNAL, 2018, 卷号: 131, 期号: 23
作者:
Qiu, Wei
;
Huang, De-Hui
;
Hou, Shi-Fang
;
Zhang, Mei-Ni
;
Jin, Tao
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
Chinese Patients
Efficacy
Phase 3
Relapsing Multiple Sclerosis
Safety
Teriflunomide
TOWER
Progression-free survival results in postmenopausal Asian women: Subgroup analysis from a phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON)
会议论文
作者:
Fazal, M.
;
Shao, Z.
;
Ellis, M. J.
;
Robertson, J. F. R.
;
Grinsted, L. M.
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/05
©版权所有 ©2017 CSpace - Powered by
CSpace